Hot Pursuit     13-May-22
Alembic Pharmaceuticals Ltd gains for third straight session
Alembic Pharmaceuticals Ltd is quoting at Rs 742, up 1.98% on the day as on 12:49 IST on the NSE. The stock is down 20.98% in last one year as compared to a 9.14% jump in NIFTY and a 8.48% jump in the Nifty Pharma index.

Alembic Pharmaceuticals Ltd gained for a third straight session today. The stock is quoting at Rs 742, up 1.98% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 1.34% on the day, quoting at 16019.3. The Sensex is at 53598.52, up 1.26%. Alembic Pharmaceuticals Ltd has slipped around 4.28% in last one month.

Meanwhile, Nifty Pharma index of which Alembic Pharmaceuticals Ltd is a constituent, has slipped around 7.35% in last one month and is currently quoting at 12424.45, up 2.29% on the day. The volume in the stock stood at 2.55 lakh shares today, compared to the daily average of 3.01 lakh shares in last one month.

The benchmark May futures contract for the stock is quoting at Rs 749, up 2.93% on the day. Alembic Pharmaceuticals Ltd is down 20.98% in last one year as compared to a 9.14% jump in NIFTY and a 8.48% jump in the Nifty Pharma index.

The PE of the stock is 18.01 based on TTM earnings ending March 22.

Previous News
  Alembic Pharmaceuticals consolidated net profit declines 18.68% in the September 2022 quarter
 ( Results - Announcements 11-Nov-22   14:55 )
  Alembic Pharma gets USFDA nod for Doxycycline Capsules
 ( Hot Pursuit - 28-Jun-24   12:20 )
  Alembic Pharmaceuticals receives USFDA approval for Desonide Cream
 ( Corporate News - 09-Dec-22   11:16 )
  Camlin Fine Sciences Ltd leads gainers in 'A' group
 ( Hot Pursuit - 30-Nov-23   12:00 )
  Alembic Pharmaceuticals' derma unit at Karakhadi clears USFDA inspection
 ( Corporate News - 13-Mar-23   09:08 )
  Alembic Pharma gets USFDA nod for Docetaxel injection
 ( Hot Pursuit - 01-Mar-23   11:59 )
  Alembic receives USFDA approval for Diclofenac Sodium Topical Solution
 ( Corporate News - 01-Dec-22   11:17 )
  Alembic Pharmaceuticals Ltd eases for fifth straight session
 ( Hot Pursuit - 22-Feb-22   13:35 )
  Alembic Pharma gains on US FDA nod for Dronedarone Tablets
 ( Hot Pursuit - 10-Jan-22   11:35 )
  Board of Alembic Pharmaceuticals appoints director
 ( Corporate News - 10-Feb-22   16:43 )
  Alembic Pharmaceuticals receives USFDA approval for Desipramine Hydrochloride Tablets
 ( Corporate News - 08-Jul-21   10:25 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top